Industry & Policy News

[Fierce Biotech] The therapy is a bispecific antibody targeting EGFR and c-MET, which are believed to be dysregulated in many tumors such as non-small cell lung cancer.

[Sanara MedTech, Inc.] Sanara MedTech Inc. announced that the Journal of Surgery has published a retrospective study on CellerateRX® Surgical Powder titled “Activated Collagen Powder Significantly Reduces Surgical Site Infections in Patients Undergoing Elective Surgery”.

[MEDSIR (PRNewswire)] MEDSIR presented the design of the MiRaDor trial, a proof-of-concept study, conducted in collaboration with Oncoclínicas & Co, which aims to evaluate the usefulness of ctDNA analysis to detect minimal residual disease in patients who had hormone receptor positive/HER2 negative early breast cancer and are at high risk of relapse.

[Inventia Life Science (Business Wire)] Inventia Life Science launched the Inventia Third Dimension Grant. This grant will allow researchers studying fundamental biology or drug development to model and test hypotheses using 3D cell cultures.

[UC Davis Health] A team of UC Davis Health researchers, led by pioneering fetal surgeon Diana Farmer and bioengineer Aijun Wang, has been awarded nearly $15 million for groundbreaking work on a spina bifida treatment.

[London Health Sciences Centre] The Baker Centre for Pancreatic Cancer at London Health Sciences Centre (LHSC) opened in 2019 as part of the vision of Rick and Shelley Baker. They generously donated $1.5 million to support pancreatic cancer care and research in the London region after Rick was diagnosed with pancreatic cancer.